Key stats
About MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKD
Expense ratio
0.68%
Home page
Inception date
Jul 25, 2019
ISIN
HK0000516697
The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Cash
Stocks76.42%
Health Technology75.33%
Bonds, Cash & Other25.03%
Cash25.03%
Stock breakdown by region
Asia96.69%
North America3.31%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history